BioElectronics Device Alleviates Dental Surgical Trauma New study shows RecoveryRx® reduces pain and inflammation and accelerates healing

FREDERICK, Md., March 25, 2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that Dr. Bartolomeo Operti MD, Chief of Anesthesia Department Day Hospital Section of Maria Adelaide Hospital and Dr. Tiziano Tealdo, Clinical Instructor at University of Genova, Valle Belbo Implant Center have completed a white paper detailing their results regarding the use of BioElectronics medical device, RecoveryRx® Therapy.

The white paper summarizes an observational study they conducted using RecoveryRx® Therapy in their post dental implant anesthesia and recovery protocol of patients at the Valle Belbo Implant Center.  Dr. Operti noted, "The RecoveryRx device significantly impacts the quality of the post-operative experience by reducing edema, inflammation and pain."

The patients reported significant reductions in pain and facial swelling using standardized visual analog measurements.  Follow-up interviews 24-48 hours following implant surgery reported return to normal chewing.  Read complete results here.  Dr. Operti had previously presented his results in September at the 16th International Implant Therapy Conference Verona, Italy.

Other Clinical Research 
BioElectronics is conducting a series of clinical research studies using its medical devices for a variety of musculoskeletal pain conditions including, osteoarthritis of the knee, acute nonspecific lower back pain, 3rd molar extraction and hernia surgical recovery. A copy of this white paper can be found at http://www.bielcorp.com/clinical-evidence/ along with details of previously completed and published clinical trials. 

MEDIA ALERT:  BioElectronics Corporation CEO, Andrew Whelan will be interviewed by Michael Yorba live tomorrow on The Traders Network on Clear Channel Network.  Interview details are as follows:

About BioElectronics Corporation  
BioElectronics Corporation is a leader in biophysics and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy; and HealFast® Therapy for dogs, cats and horses.  For more information, please visit www.bielcorp.com.

Contact:

Paul Knopick 
940.262.3584 
pknopick@eandecommunications.com   

SOURCE BioElectronics Corporation



RELATED LINKS
http://www.bielcorp.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.